Novel compounds of the formula (I), in which D, W, X, Y, T, m and R.sup.1 have the meaning indicated in Patent claim 1, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumours.